LX3070 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

27 results for “LX3070”

Trials

View all 17 →

Study to Compare the Pharmacokinetics, Safety and Tolerability of the Pediatric and Adult Branaplam Formulation in Healthy Adults and the Effect of Food on the Latter.

9 participants · First posted Apr 15, 2022

Diving into the noradrenergic system : Role of the alpha2C-adrenergic receptors NA2C-TEP-IRM

165 participants · First posted Apr 24, 2026

Suitability of 11C-ORM-13070 as a PET Tracer

18 participants · First posted Aug 15, 2008

Drugs

HLX307

PD-163070

JAB-BX300

News

Lexeo to Acquire Mantle Therapeutics for Up to $21.3M, Adding Four Frataxin-Targeting FA Programs

First Patient Dosed in Pioneering ZOLAR Trial of TLX300-CDx for Advanced Soft Tissue Sarcoma

Lexeo Therapeutics Reports Promising Phase I/II Data for Gene Therapy LX2020 in Rare Heart Disease

Page 1 of 3